CYTK Cytokinetics
$50.78 -1.32%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-1.32%
YTD
-20.10%
P/E
—
P/B
15.68
ROE
-131.2%
Div yield
—
Beta
0.98
Market cap
$7.2B
RSI (14)
30
Next earnings
Feb 22, 2027
Same sector · Health Care
Compare CYTK with NVO and JNJ →Follow CYTK in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$51.27
Close
$50.78
Day high
$53.45
Day low
$50.60
Volume
1.4M
Latest headlines
Cytokinetics Touts MYQORZO Launch Momentum, Plans New FDA Filing
Yahoo Finance · Nov 17
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · Nov 16
Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM
Yahoo Finance · Nov 16
Cytokinetics’ MYQORZO Gains Ground as Company Plans Push Into New Heart-Disease Market
Yahoo Finance · Nov 16
Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
Yahoo Finance · Nov 9
FDA Decision Watch: Summit’s Lung Cancer Drug, Cytokinetics’ Heart Therapy And Teva’s Igalmi In Spotlight This Week
Yahoo Finance · Nov 9
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 4, 2026 View → 8-K Nov 4, 2026 View → 8-K Aug 28, 2026 View → 8-K Aug 13, 2026 View → 10-Q Aug 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell CYTK. Try it in the Lab to size a position and see the risk.